WallachBeth Capital announces ABVC BioPharma private placement closing
1 report, 1 independent
Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
WallachBeth Capital announced that ABVC BioPharma closed a private placement of original issue discount senior convertible promissory notes (OID Notes). The offering generated aggregate gross proceeds of approximately $3.39 million.
From prnewswire.com
Why it matters
The private placement provides capital to ABVC BioPharma, which issued the notes with a maturity date of June 30, 2027. The notes are convertible into common stock after eight months.
From prnewswire.com
Who's involved
- PR NewswireDistributor of the corporate announcement
Keep exploring
The entities involved
-
Jersey City
city in New Jersey, United States
-
PR Newswire
American distributor of press releases